Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(2.44)
# 3,071
Out of 4,581 analysts
20
Total ratings
41.2%
Success rate
4.6%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Upgraded: Buy | $280 | $265.53 | +5.45% | 1 | Jul 16, 2026 | |
| NAGE Niagen Bioscience | Initiated Coverage: Buy | $9 | $3.22 | +179.50% | 1 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Initiated Coverage: Buy | $27 | $5.79 | +366.32% | 1 | Jul 2, 2026 | |
| SMTI Sanara MedTech | Initiated Coverage: Buy | $35 | $30.25 | +15.70% | 1 | Jun 17, 2026 | |
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.483 | +624.64% | 1 | May 20, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $44.81 | - | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $8.06 | +24.07% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $387.64 | -3.26% | 1 | May 7, 2026 | |
| BIIB Biogen | Upgraded: Buy | $245 | $209.23 | +17.10% | 1 | May 1, 2026 | |
| INGN Inogen | Initiated Coverage: Buy | $12 | $6.43 | +86.63% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $14.63 | +9.36% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $94.26 | +23.06% | 1 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $4.33 | +361.89% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.66 | +261.45% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $15.54 | +138.17% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $5.05 | +117.82% | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $9.40 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $40.16 | n/a | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $3.64 | n/a | 1 | Mar 18, 2025 |
Johnson & Johnson
Jul 16, 2026
Upgraded: Buy
Price Target: $280
Current: $265.53
Upside: +5.45%
Niagen Bioscience
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $3.22
Upside: +179.50%
Arcturus Therapeutics Holdings
Jul 2, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $5.79
Upside: +366.32%
Sanara MedTech
Jun 17, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $30.25
Upside: +15.70%
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.483
Upside: +624.64%
Sionna Therapeutics
May 20, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.81
Upside: -
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $8.06
Upside: +24.07%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $387.64
Upside: -3.26%
Biogen
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $209.23
Upside: +17.10%
Inogen
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.43
Upside: +86.63%
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $14.63
Upside: +9.36%
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $94.26
Upside: +23.06%
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $4.33
Upside: +361.89%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $1.66
Upside: +261.45%
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $15.54
Upside: +138.17%
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $5.05
Upside: +117.82%
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $9.40
Upside: n/a
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $40.16
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: $13
Current: $3.64
Upside: n/a